UNSPSC 51373412: Ascorbic acid/hydrocodone/pheniramine/potassium citrate/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373412 Ascorbic acid/hydrocodone/pheniramine/potassium citrate/pyrilamine is a Commodity code that in practice covers pharmaceutical products and medical supplies—particularly parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems—purchased by state correctional departments and county health agencies. The Washington State Department of Corrections and Seminole County, Florida represent the recent issuing bodies; both are soliciting through competitive bidding (RFQ and IFB respectively) to supply healthcare products to incarcerated populations and community health programs. Work under this code includes sourcing, preparing, and delivering controlled and non-controlled pharmaceutical products on tight timelines—the Washington DOC requires parenteral nutrition bags within 24 hours of order and other IV solutions within 8 hours—with full compliance to state licensure, background clearance, and insurance requirements including cyber liability and professional liability coverage.

Recent activity centers on Washington State and Florida. The Washington State Department of Corrections posted RFQQK13020 on September 8, 2026, with responses due October 7, 2026, seeking parenteral products and services across eight correctional facilities in three regions; DOC anticipates awarding up to three contractors per region under a contract term running November 26, 2026 through June 30, 2030, with pricing fixed for the first two years and strong preference signals for small, minority-owned, women-owned, and veteran-owned businesses. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, soliciting 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to Sanford; the initial contract runs two years with a one-year renewal option. Both solicitations require vendor compliance with state procurement set-asides, E-Verify, drug-free workplace certification, and specified insurance minimums.